Ftse Mib
33.968,78
1,01%
DAX
18.175,21
1,01%
S&P 500
5.180,74
1,03%
NASDAQ
16.349,25
1,19%
Bitcoin
63.462,70
-0,84%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Legend Biotech Corporation (LEGN) Legend Biotech Corporation (LEGN) Notizie

Legend Biotech Corporation

LEGN
45,26
-0,15 (-0,33%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:08:11
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/4/202419:05BWCARVYKTI® (ciltacabtagene autoleucel) Approved by the..
11/4/202414:00BWLegend Biotech to Host Investor Conference Call on First..
06/4/202405:30BWLegend Biotech’s CARVYKTI® (ciltacabtagene autoleucel)..
19/3/202413:30BWLegend Biotech Announces Publication of Inaugural..
15/3/202420:15BWCARVYKTI® (ciltacabtagene autoleucel) Receives..
11/3/202412:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/3/202412:00BWLegend Biotech Reports Fourth Quarter and Full Year 2023..
11/3/202411:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
29/2/202400:46EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
28/2/202401:47EDGAR2Form 144 - Report of proposed sale of securities
23/2/202419:10EDGAR2Form 144 - Report of proposed sale of securities
23/2/202413:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/2/202413:15BWLegend Biotech Announces Positive CHMP Opinion for CARVYKTI®..
15/2/202402:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202414:00BWLegend Biotech to Host Investor Conference Call on Fourth..
23/1/202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202413:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202417:28BWLegend Biotech Announces Closing of License Transaction for..
03/1/202414:30BWLegend Biotech Announces Closing of License Transaction for..
02/1/202414:30BWLegend Biotech to Participate in the 42nd Annual J.P. Morgan..
27/12/202316:00EDGAR2Form 144 - Report of proposed sale of securities
22/12/202321:38EDGAR2Form 144 - Report of proposed sale of securities
22/12/202321:21EDGAR2Form 144 - Report of proposed sale of securities
21/12/202323:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202322:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202320:31EDGAR2Form 144 - Report of proposed sale of securities
12/12/202301:30BWPatient-Reported Outcomes from the CARTITUDE-4 Study Showed..
20/11/202312:25IHMARKETNEWSMonday’s Wall Street Highlights: GM, Microsoft, Citigroup,..
20/11/202312:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202312:00BWLegend Biotech Reports Third Quarter 2023 Results and Recent..
13/11/202315:16DJNLegend Biotech Subsidiary in License Agreement With Novartis
13/11/202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202314:30BWLegend Biotech Announces Exclusive, Global License Agreement..
07/11/202314:30BWLegend Biotech to Host Investor Conference Call on..
02/11/202314:17BWLegend Biotech to Showcase Leadership in Multiple Myeloma..
17/10/202323:39EDGAR2Form 144 - Report of proposed sale of securities
17/10/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/10/202323:20EDGAR2Form 144 - Report of proposed sale of securities
27/9/202318:02EDGAR2Form 144 - Report of proposed sale of securities
25/9/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/9/202322:20EDGAR2Form 144 - Report of proposed sale of securities
22/9/202322:10EDGAR2Form 144 - Report of proposed sale of securities
18/9/202322:41EDGAR2Form 144 - Report of proposed sale of securities
28/8/202316:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/8/202322:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202312:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202312:00BWLegend Biotech Reports Second Quarter 2023 Results and..
03/8/202314:30BWLegend Biotech to Host Investor Conference Call on..
20/7/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: 45,41 Min: 44,7201 Max: 45,525
Chiusura: 45,41

La tua Cronologia

NASDAQ
LEGN
Legend Biotech
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network